CELL INTELLIGENCE · 肿瘤细胞治疗研究

Itolizumab 调节效应细胞上的激活性和抑制性信号，增强其对 CD318+肿瘤细胞系的细胞毒性

Itolizumab regulates activating and inhibitory signals on effector cells, improving their cytotoxicity against CD318+ tumor cell lines.

局部晚期不可切除非小细胞肺癌患者外周血淋巴细胞群体的特征

Characteristics of Peripheral Blood Lymphocyte Populations in Patients with Locally Advanced Unresectable Non-Small Cell Lung Cancer.

在局部晚期 NSCLC（IIIB-IIIC 期）患者中，免疫活性外周血细胞之间显现出的多向性变化，无疑可被视为该队列中系统性免疫紊乱（继发性免疫缺陷）的标志。

氧化还原状态变化在慢性淋巴细胞白血病发病机制中的作用

The Role of Changes in the Redox Status in the Pathogenesis of Chronic Lymphocytic Leukemia.